Park C, Cha HJ, Hong SH, Kim HS, et al. Combination Therapy with Betulinic Acid and TRAIL Increases ROS-Dependent Cytotoxicity and Inhibits PI3K/Akt Signaling in Human Bladder Cancer Cells. Biomol Ther (Seoul) 2026;34:641-651.
PMID: 42059034